Email ID
Password
Scrip   
RNAi firms Silence Therapeutics and Intradigm combine
17 December 2009
Sukaina Virji

Silence Therapeutics of the UK and privately-held US firm Intradigm are to merge in a stock-based deal that will create an enlarged RNAi-focused company with enhanced drug delivery options.

Trading in the UK company's shares has resumed following suspension from AIM (the London...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36